68
Participants
Start Date
January 10, 2003
Primary Completion Date
December 19, 2012
Study Completion Date
May 7, 2013
Doxorubicin, Rituxan, Cyclophosphamide, Vincristine and Prednisone
"Cycle 1 Doxil 40 mg/m2 iv day 1 over a minimum of 60 min.~Cyclophosphamide 750 mg/m2 iv day 1 over a minimum of 60 min.~Vincristine 1.4 mg/m2 iv bolus day 1 (2.0 mg maximum).~Prednisone 100 mg po days 1-5.~Cycle 2 until study completion~Doxil 40 mg/m2 iv day 1~Rituxan 375 mg/m2 iv day 1~Cyclophosphamide 750 mg/m2 iv day 1~Vincristine 1.4 mg/m2 iv bolus day 1 (2.0 mg maximum)~Prednisone 100 mg po days 1-5~* 1 cycle = 21 days.~* Continue treatment until 2 cycles beyond documentation of CR for a maximum of 8 cycles."
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles
Collaborators (1)
Ortho Biotech, Inc.
INDUSTRY
University of Southern California
OTHER